TTK Healthcare [TTKHLTCARE] vs Pfizer [PFIZER] Detailed Stock Comparison
TTK Healthcare
NSE
Loading...
Pfizer
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: TTK Healthcare wins in 8 metrics, Pfizer wins in 12 metrics, with 0 ties. Pfizer appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | TTK Healthcare | Pfizer | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.54 | 29.77 | TTK Healthcare |
| Price-to-Book Ratio | 1.51 | 5.42 | TTK Healthcare |
| Debt-to-Equity Ratio | 2.27 | 2.57 | TTK Healthcare |
| PEG Ratio | 0.85 | 29.84 | TTK Healthcare |
| EV/EBITDA | 27.32 | 28.60 | TTK Healthcare |
| Profit Margin (TTM) | 7.69% | 33.65% | Pfizer |
| Operating Margin (TTM) | 0.22% | 35.96% | Pfizer |
| EBITDA Margin (TTM) | 0.22% | 35.96% | Pfizer |
| Return on Equity | 7.67% | 19.65% | Pfizer |
| Return on Assets (TTM) | 6.37% | 9.32% | Pfizer |
| Free Cash Flow (TTM) | $-168.16M | $6.32B | Pfizer |
| Dividend Yield | 0.74% | 1.27% | Pfizer |
| 1-Year Return | -28.62% | -13.51% | Pfizer |
| Price-to-Sales Ratio (TTM) | 1.98 | 10.02 | TTK Healthcare |
| Enterprise Value | $7.83B | $201.68B | Pfizer |
| EV/Revenue Ratio | 0.95 | 8.84 | TTK Healthcare |
| Gross Profit Margin (TTM) | 55.03% | 65.79% | Pfizer |
| Revenue per Share (TTM) | $580 | $499 | TTK Healthcare |
| Earnings per Share (Diluted) | $44.64 | $167.76 | Pfizer |
| Beta (Stock Volatility) | 0.30 | 0.13 | Pfizer |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
TTK Healthcare vs Pfizer Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| TTK Healthcare | 0.12% | -2.90% | -15.87% | -6.48% | -7.17% | -18.75% |
| Pfizer | 0.10% | 0.23% | -5.71% | 20.06% | 23.82% | -3.87% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| TTK Healthcare | -28.62% | 35.35% | 126.25% | 43.66% | 201.25% | 300.81% |
| Pfizer | -13.51% | 19.04% | 9.92% | 122.81% | 339.32% | 519.48% |
Performance & Financial Health Analysis: TTK Healthcare vs Pfizer
| Metric | TTKHLTCARE | PFIZER |
|---|---|---|
| Market Information | ||
| Market Cap | ₹16.27B | ₹228.51B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 6,519 | 15,961 |
| 90 Day Avg. Volume | 6,375 | 31,877 |
| Last Close | ₹1,143.30 | ₹5,107.00 |
| 52 Week Range | ₹1,101.05 - ₹1,893.95 | ₹3,701.00 - ₹6,451.15 |
| % from 52W High | -39.63% | -20.84% |
| All-Time High | ₹1,893.95 (Sep 09, 2024) | ₹6,451.15 (Sep 02, 2024) |
| % from All-Time High | -39.63% | -20.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.08% |
| Quarterly Earnings Growth | -0.59% | 0.85% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.34% |
| Operating Margin (TTM) | 0.00% | 0.36% |
| Return on Equity (TTM) | 0.08% | 0.20% |
| Debt to Equity (MRQ) | 2.27 | 2.57 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹753.73 | ₹921.88 |
| Cash per Share (MRQ) | ₹605.17 | ₹608.26 |
| Operating Cash Flow (TTM) | ₹338.96M | ₹6.60B |
| Levered Free Cash Flow (TTM) | ₹816.57M | ₹5.01B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.74% | 1.27% |
| Last 12-Month Dividend | ₹10.00 | ₹70.00 |
Valuation & Enterprise Metrics Analysis: TTK Healthcare vs Pfizer
| Metric | TTKHLTCARE | PFIZER |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.54 | 29.77 |
| Forward P/E | N/A | 29.84 |
| PEG Ratio | 0.85 | 29.84 |
| Price to Sales (TTM) | 1.98 | 10.02 |
| Price to Book (MRQ) | 1.51 | 5.42 |
| Market Capitalization | ||
| Market Capitalization | ₹16.27B | ₹228.51B |
| Enterprise Value | ₹7.83B | ₹201.68B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.95 | 8.84 |
| Enterprise to EBITDA | 27.32 | 28.60 |
| Risk & Other Metrics | ||
| Beta | 0.30 | 0.13 |
| Book Value per Share (MRQ) | ₹753.73 | ₹921.88 |
Financial Statements Comparison: TTK Healthcare vs Pfizer
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TTKHLTCARE | PFIZER |
|---|---|---|
| Revenue/Sales | ₹2.26B | ₹5.92B |
| Cost of Goods Sold | ₹1.02B | ₹2.02B |
| Gross Profit | ₹1.25B | ₹3.89B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹4.88M | ₹2.11B |
| EBITDA | ₹206.11M | ₹2.72B |
| Pre-Tax Income | ₹176.54M | ₹4.26B |
| Income Tax | ₹46.54M | ₹948.60M |
| Net Income (Profit) | ₹129.99M | ₹3.31B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TTKHLTCARE | PFIZER |
|---|---|---|
| Cash & Equivalents | ₹90.06M | ₹4.95B |
| Total Current Assets | ₹11.04B | ₹35.13B |
| Total Current Liabilities | ₹2.11B | ₹5.70B |
| Long-Term Debt | ₹17.73M | ₹676.20M |
| Total Shareholders Equity | ₹10.65B | ₹42.17B |
| Retained Earnings | ₹9.40B | N/A |
| Property, Plant & Equipment | ₹808.99M | ₹1.72B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TTKHLTCARE | PFIZER |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TTKHLTCARE | PFIZER |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 6,519 | 15,961 |
| Average Daily Volume (90 Day) | 6,375 | 31,877 |
| Shares Outstanding | 14.13M | 45.75M |
| Float Shares | 3.27M | 15.12M |
| % Held by Insiders | 0.77% | 0.67% |
| % Held by Institutions | 0.03% | 0.17% |
Dividend Analysis & Yield Comparison: TTK Healthcare vs Pfizer
| Metric | TTKHLTCARE | PFIZER |
|---|---|---|
| Last 12-Month Dividend | ₹10.00 | ₹70.00 |
| Last 12-Month Dividend Yield | 0.74% | 1.27% |
| 3-Year Avg Annual Dividend | ₹13.33 | ₹46.67 |
| 3-Year Avg Dividend Yield | 0.85% | 0.58% |
| 3-Year Total Dividends | ₹40.00 | ₹140.00 |
| Ex-Dividend Date | Jul 18, 2025 | Jul 09, 2025 |